BD Unveils Latest Diagnostic Innovations at ECCMID
New Synapsys microbiology informatics solution will be demonstrated at the event
New Synapsys microbiology informatics solution will be demonstrated at the event
NYU school of medicine becomes the most recent cancer center to join PanFAM-1 prospective study
During the American Association for Cancer Research 2018 Annual Meeting, SelectScience recognized cutting-edge products and technologies advancing life sciences research
A recent study from University of Edinburgh aims to pinpoint genes that may be associated with depression
Research reveals that acquired HER2 mutations confer resistance to hormone therapy in ER-positive metastatic breast cancer
Team heading to Chicago, USA, to interview scientists at the forefront of cancer research and report on the newest technologies
Exciting new discovery describes the mechanism of action of a new class of antibiotics
A novel technique developed by Stanford scientists will transform cancer research from years of painstaking work to a task accomplished in months
Five Prime Therapeutics and Personal Genome Diagnostics collaborate to develop new diagnostic assay for gastric and gastrointestinal cancers
Presentations on novel developments in CRISPR screening technologies and applications for the DriverMap™ targeted RNA expression profiling assay
New 2D tube with external thread from Micronic provides a simpler way to build your genomic libraries
Non-invasive, cell-free pre-natal DNA testing to be performed on QIAGEN’s GeneReader NGS System
University of Sheffield scientists discover nine novel genes for osteoarthritis
A blood test for cancer DNA could predict if a woman is responding to the new breast cancer drug palbociclib, months earlier than current tests
New blood test identifies 12 metabolic sub-types of autism spectrum disorder
New blood test provides a unique new framework for early detection of the most common cancers